期刊文献+

LMAN2在HR阳性乳腺癌组织中的表达与患者预后的关系及其对MCF-7细胞增殖和迁移的影响

Relationship between LMAN2 expression in HR-positive breast cancer tissues and patient prognosis and its effect on proliferation and migration of MCF-7 cells
原文传递
导出
摘要 目的:探究甘露糖结合凝集素2(LMAN2)在激素受体(HR)阳性乳腺癌组织中的表达水平与乳腺癌患者预后的关系及其对MCF-7细胞增殖和迁移的影响。方法:通过TCGA、Bc-GenExMiner、GEPIA和Kaplan-Meier Plotter数据库分析LMAN2在乳腺癌组织和正常乳腺组织中的差异性表达及其与患者预后的关系。采用小RNA干扰技术将si-LMAN2#1、si-LMAN2#2及si-NC转染至MCF-7细胞,将过表达LMAN载体(pc-LMAN)及空载体pcDNA3.1阴性对照(pc-NC)转染至MCF-7细胞,实验分为si-LMAN2#1、si-LMAN2#2、si-NC、pc-LMAN2和pc-NC组。通过qPCR和WB实验检测各组细胞中LMAN2 mRNA和蛋白的表达水平,CCK-8、克隆形成、Transwell迁移、WB等实验检测敲低和过表达LMAN 2对MCF-7细胞增殖、克隆形成、迁移及AKT信号通路相关蛋白表达的影响。结果:LMAN2在乳腺癌组织中的表达水平显著高于正常乳腺组织(P<0.001)。HR阳性乳腺癌组织中LMAN2表达水平显著高于HR阴性乳腺癌组织(P<0.001);LMAN2高表达与HR阳性乳腺癌患者不良预后有关联。敲低LMAN2可显著降低MCF-7细胞的增殖和迁移能力(P<0.01或P<0.001),过表达LMAN2可显著提高MCF-7细胞的增殖和迁移能力(均P<0.001)。敲低LMAN2组MCF-7细胞中PTEN和P21蛋白表达水平均显著升高,p-AKT蛋白表达水平显著降低(均P<0.01)。结论:LMAN2在乳腺癌组织和HR阳性乳腺癌组织中高表达,且与不良预后有关联。LMAN2高表达与MCF-7细胞增殖和迁移有关联,其作用机制可能涉及AKT信号通路。 Objective:To explore the relationship between the expression level of mannose-binding lectin 2(LMAN2) in hormone receptor(HR)-positive breast cancer tissues and patient prognosis as well as its effects on the proliferation and migration of MCF-7 cells.Methods:The differential expression of LMAN2 in breast cancer tissues and normal breast tissues as well as its relationship with patients' prognosis were analyzed by TCGA,Bc-GenExMiner,GEPIA and Kaplan-Meier Plotter databases.si-LMAN2#1,si-LMAN2#2 and si-NC were transfected into MCF-7 cells using small RNA interference technology,and the LMAN overexpression vector(pc-LMAN) and empty vector pcDNA3.1 negative control(pc-NC) were transfected into MCF-7 cells;and accordingly,the experimental groups were named si-LMAN2#1 group,si-LMAN2#2 group,si-NC group,pc-LMAN2 group and pc-NC group.The mRNA and protein expression levels of LMAN2 in MCF-7 cells of each group were detected by qPCR and WB assay,respectively.The effects of knockdown and overexpression of the LMAN2 on the proliferation,colony formation and migration as well as the expression of AKT signaling pathway-related proteins in MCF-7 cells were detected using CCK-8,colony formation,Transwell migration and WB assay,etc.Results:The expression level of LMAN2 in breast cancer tissues was significantly higher than that in normal breast tissues(P<0.001),and the expression of LMAN2 in HR-positive breast cancer tissues was significantly higher than that in HR-negative breast cancer tissues(P<0.001).In contrast to low LMAN2 expression,high expression of LMAN2 was associated with poor prognosis in HR-positive breast cancer patients.Knockdown of LMAN2 significantly inhibited the proliferation and migration abilities of MCF-7 cells(P<0.01 or P<0.001),while overexpression of LMAN2 significantly enhanced the proliferation and migration abilities of MCF-7 cells(all P<0.001).The protein expression levels of PTEN and P21 in MCF-7 cells with LMAN2 knockdown were significantly elevated,while the protein expression of p-AKT was significantly decreased(all P<0.01).Conclusion:LMAN2 is highly expressed in breast cancer tissues and HR-positive breast cancer tissues and is associated with poor prognosis.The high expression of LMAN2 is associated with the proliferation and migration of MCF-7 cells,and the mechanism may involve the AKT signaling pathway.
作者 延常姣 黄美玲 肖晶晶 凌瑞 YAN Changjiao;HUANG Meiling;XIAO Jingjing;LING Rui(Department of Thyroid,Breast and Vascular Surgery,Xijing Hospital,Air Force Medical University,Xi′an 710032,Shaanxi,China)
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2024年第1期47-53,共7页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金(No.81572917) 陕西省重点研发计划(No.2022ZDLSF02-07) 陕西省自然科学基础研究计划(No.2023-JC-QN-0965)。
关键词 甘露糖结合凝集素2 激素受体阳性 乳腺癌 MCF-7细胞 增殖 迁移 AKT信号通路 mannose-binding lectin 2(LMAN2) hormone receptor(HR)-positive breast cancer MCF-7 cell proliferation migration AKT signaling pathway
  • 相关文献

参考文献3

二级参考文献50

  • 1薛锋杰,代志军,王西京,刘小旭,赵世平,康华峰,闵卫利.抑癌基因PTEN在乳腺癌中的表达及其临床意义[J].实用医技杂志,2004,11(10B):2114-2116. 被引量:4
  • 2时志民,柳继兴,刘惠民,王蕾,王如美.乳腺癌中EBP50、β-catenin的表达及意义研究[J].实用心脑肺血管病杂志,2010,18(12):1840-1841. 被引量:1
  • 3刘臻,王贵友,崔东旭,刘宝林,张小薄,马文锋,张强.乳腺癌中β-catenin基因突变和表达的研究[J].中国普通外科杂志,2007,16(1):55-57. 被引量:3
  • 4Carvalho S,Schmitt F. Potential role of PI3K inhibitors in the treatment of breast cance[J].FUTURE ONCOLOGY,2010,(08):1251-1263.doi:10.2217/fon.10.97.
  • 5Noh EM,Lee YR,Chay KO. PTEN and the PI3-kinasepathway in cancer[J].Ann Review Pathol,2009,(02):127-150.
  • 6Wang DS,Ching TT,St Pyrek J. Biotinylated phosphatidylinositol 3,4,5-trisphosphate as affinity ligand[J].Analytical Biochemistry,2000,(02):301-307.doi:10.1006/abio.2000.4525.
  • 7Tokunaga E,Oki E,Egashira A. Deregulation of the Akt pathway in human cancer[J].Current Cancer Drug Targets,2008,(01):27-36.
  • 8Li Y,Corradetti MN,Inoki K. TSC2:filling the GAP in the mTOR signaling pathway[J].Trends in Biochemical Sciences,2004,(01):32-38.doi:10.1016/j.tibs.2003.11.007.
  • 9Lopez-Knowles E,O Tople SA,McNeil CM. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality[J].International Journal of Cancer,2010,(05):1121-1131.
  • 10Marty B,Maire V,Gravier E. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells[J].Breast Cancer Research,2008,(06):R101.doi:10.1186/bcr2204.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部